ST
CRMD icon

Spot Trading’s CorMedix CRMD Stock Holding History

Spot Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,700
Closed -$135K – 2968
2016
Q4 		$135K Hold
17,700
– – ﹤0.01% 2089
2016
Q3 		$223K Buy
+17,700
New +$165K ﹤0.01% 2019
2016
Q2 		– Sell
-2,500
Closed -$33K – 3375
2016
Q1 		$33K Sell
2,500
-24,000
-91% -$233K ﹤0.01% 2920
2015
Q4 		$269K Buy
26,500
+2,500
+10% +$28.8K ﹤0.01% 2296
2015
Q3 		$239K Buy
24,000
+8,440
+54% +$130K ﹤0.01% 2571
2015
Q2 		$302K Sell
15,560
-300
-2% -$10.3K ﹤0.01% 2439
2015
Q1 		$780K Buy
+15,860
New +$376K 0.01% 1797

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Spot Trading's CRMD Position: Q1 2017 in Review

Spot Trading sold out of CorMedix (CRMD) in Q1 2017, closing a stake of 17,487 shares — an estimated $134K sold.

Spot Trading first reported a position in CRMD in Q2 2015 and held it in 6 quarters. The position peaked at $257K in Q4 2015. 30 funds tracked by Wall St. Rank hold CRMD as of Q1 2017.

  • Spot Trading reported no remaining CorMedix position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 17,487 CorMedix shares in Q1 2017, an estimated $134K.
  • Spot Trading first reported a position in CorMedix in Q2 2015 and held it in 6 quarters.
  • Spot Trading's CorMedix position peaked at $257K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held CorMedix as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.